No Aspirin Needed After LVAD, ARIES-HM3 Trial Says
PHILADELPHIA — Dropping aspirin from the antithrombotic regimen after HeartMate 3 left ventricular assist device (LVAD) implantation appeared safer than the usual combination approach in the ARIES-HM3 trial. Atop warfarin or other vitamin K antagonist therapy, placebo was noninferior to low-dose aspirin for the primary composite endpoint of survival free of stroke, pump thrombosis, major […]
Skipping Antiplatelets Altogether Not Such a Bad Idea for Select TAVR Patients
Following transcatheter aortic valve replacement (TAVR), the optimal antithrombotic regimen for some people may be no antithrombotics at all, according to provocative registry data from Japan. Compared with the single antiplatelet (SAPT) or dual antiplatelet (DAPT) approaches for TAVR patients without any other indications for antiplatelet or anticoagulation therapy, the non-antithrombotic strategy was not associated […]